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The persistence of associative memories linked to the rewarding properties of drugs
of abuse is a core underlying feature of the addiction process. Opiate class drugs in
particular, possess potent euphorigenic effects which, when linked to environmental
cues, can produce drug-related “trigger” memories that may persist for lengthy periods
of time, even during abstinence, in both humans, and other animals. Furthermore, the
transitional switch from the drug-naïve, non-dependent state to states of dependence
and withdrawal, represents a critical boundary between distinct neuronal and molecular
substrates associated with opiate-reward memory formation. Identifying the functional
molecular and neuronal mechanisms related to the acquisition, consolidation, recall, and
extinction phases of opiate-related reward memories is critical for understanding, and
potentially reversing, addiction-related memory plasticity characteristic of compulsive
drug-seeking behaviors. The mammalian prefrontal cortex (PFC) and basolateral nucleus
of the amygdala (BLA) share important functional and anatomical connections that are
involved importantly in the processing of associative memories linked to drug reward.
In addition, both regions share interconnections with the mesolimbic pathway’s ventral
tegmental area (VTA) and nucleus accumbens (NAc) and can modulate dopamine
(DA) transmission and neuronal activity associated with drug-related DAergic signaling
dynamics. In this review, we will summarize research from both human and animal
modeling studies highlighting the importance of neuronal and molecular plasticity
mechanisms within this circuitry during critical phases of opiate addiction-related learning
and memory processing. Specifically, we will focus on two molecular signaling pathways
known to be involved in both drug-related neuroadaptations and in memory-related
plasticity mechanisms; the extracellular-signal-regulated kinase system (ERK) and the
Ca2+/calmodulin-dependent protein kinases (CaMK). Evidence will be reviewed that
points to the importance of critical molecular memory switches within the mammalian
brain that might mediate the neuropathological adaptations resulting from chronic opiate
exposure, dependence, and withdrawal.
Keywords: opiates, addiction, memory, dopamine, amygdala, prefrontal, molecular
Rosen et al. Molecular basis of opiate addiction memories
INTRODUCTION
The persistent and compulsive behavioral patterns associated
with opiate addiction depend largely on the ability of opiate-
class drugs to produce powerful associative memories linked
to their intense, euphorigenic properties. Indeed, the ability
of environmental cues to trigger opiate-related associative
memories is arguably the primary driver of the addiction cycle,
characterized by repeated cycles of chronic use, withdrawal and
ultimately, relapse. While many classes of abused drugs share
the ability to elicit rewarding effects and dependence, opiate-
class drugs, whether illicit or prescribed, stand alone in their
ability to not only evoke intensely subjective experiences of
pleasure, but also in terms of their capacity to produce both
severe physiological and psychological withdrawal effects. The
severity of these opiate-related effects is illustrated not only by the
exponentially increasing and global spread of opiate addiction,
with recent epidemiological reports suggesting approximately
15.5 million people worldwide (Degenhardt et al., 2014), but also
by the well-established and documented clinical intractability of
opiate dependence.
Decades of both clinical and basic neuroscience research
have revealed many underlying neurobiological mechanisms
responsible for the motivational properties of opiates. However,
the neural processes responsible for the encoding, recall, and
extinction of opiate-related drug reward memories have only
recently begun to be understood. For example, how do early,
acute drug-experiences become encoded in the brains emotional
memory circuits? Once chronic exposure and dependence have
developed, do separate neuronal or molecular memory substrates
come online during the processing of addiction-related memory?
Do these neural memory adaptations lead to increased resistance
and/or increased motivational salience linked to drug-associated
cues? Adding to the complexity of addiction-related memory
processing is the recognition that distinct phases of learning
and memory involve different molecular and neuroanatomical
substrates. Drug-related associative memories must first be
encoded and consolidated via associative neuronal andmolecular
mechanisms. These drug-related memories must then be stored
in terms of their temporal and contextual information. Finally,
recall of these associative memories can serve as triggers,
responsible for compulsive drug seeking and relapse, even many
years after successful abstinence has been established.
Elucidating the neural mechanisms responsible for the
formation and persistence of opiate-related associative memories
has the potential for opening up new therapeutic vistas for
both the prevention and/or reversal of the profound effects
on neuronal learning and memory plasticity underlying the
development of opiate dependence. In particular, understanding
the underlying molecular pharmacological substrates linked to
these phenomenamay reveal potential new pharmacotherapeutic
targets for the treatment of protracted opiate dependence
and/or relapse. In this review, we will examine recent evidence
implicating the mammalian prefrontal cortex (PFC) and
basolateral amygdala (BLA) as critical neural regions involved
in the control of opiate-related addiction memory phenomena.
Specifically, we will examine how functional interactions not
only within the BLA-PFC circuit, but also with associated
mesocorticolimbic dopamine (DA) signaling, may control the
processing of opiate-addiction related associative memories. As
will be described, emerging evidence is suggesting that opiate
exposure state represents a functional boundary between distinct
molecular and neuronal mechanisms within this circuitry,
mediating how the brain acquires, recalls, and ultimately may
extinguish, addiction-related memories.
NEURAL MECHANISMS UNDERLYING THE
ENCODING OF ASSOCIATIVE OPIATE
REWARD MEMORIES
Opiate class drugs, either illicit or prescribed, are capable of
producing potent rewarding effects which quickly lead to states
of physiological (somatic) and/or psychological dependence.
Given the well-documented euphorigenic properties of opiates,
decades of research have explored the primary neural regions
and pathways responsible for these acute reinforcing effects and
how the mammalian brain encodes the environmental and/or
internal cues associated with these phenomena. Importantly,
considerable evidence has demonstrated that the neural
mechanisms responsible for these acute, rewarding properties
can be dissociated from those mediating the secondary effects
of opiates, such as the formation of drug-related associative
memories and/or withdrawal-related motivational and somatic
phenomena. In this context, the mesolimbic DA pathway
comprising the ventral tegmental area (VTA) and its associated
DAergic (A10) neuronal projections to the nucleus accumbens
(NAc) has consistently been identified as the most critical neural
region underlying the acute rewarding stimulus properties
of opiates, in both humans and other mammals (Wise, 1989;
Wise and Rompre, 1989; Nader and van der Kooy, 1997;
Koob and Volkow, 2010). For example, rats will directly
self-administer opiates or related derivatives into the VTA
(David and Cazala, 1994; Devine and Wise, 1994; Steidl et al.,
2015) and microinfusions of morphine into the VTA produce
powerful associative reward memories measured in place
conditioning procedures (CPP; Nader and van der Kooy, 1997;
Olmstead and Franklin, 1997; Bishop et al., 2011; Lintas et al.,
2011). Interestingly, infusions of opiates into regions extrinsic
to the VTA but which share direct or indirect functional
connections, such as the basolateral amygdala (BLA), caudate
putamen, medial prefrontal cortex (mPFC), hippocampus,
lateral hypothalamus, pedunculopontine tegmental nucleus
(PPT), ventral pallidum or nucleus accumbens (NAc), generally
fail to produce primary reinforcing behavioral effects (Olmstead
and Franklin, 1997).
Nevertheless, while the acute rewarding properties of opiates
may depend primarily upon the VTA, several of the neural
regions noted above are capable of modulating the reinforcing
effects of opiates. For example, excitotoxic lesions of the
brainstem PPT are capable of abolishing both operant opiate
self-administration (Olmstead and Franklin, 1994; Olmstead
et al., 1998) and opiate reward measured in Pavlovian
associative conditioning procedures such as the conditioned
Frontiers in Neuroscience | www.frontiersin.org 2 November 2015 | Volume 9 | Article 399
Rosen et al. Molecular basis of opiate addiction memories
place preference paradigm (CPP), which involves conditioning
an experimental animal in either a drug-paired or vehicle-paired
environment and then testing whether the animal develops a
conditioned preference for the environment previously paired
with the effects of the drug (Bechara and van der Kooy, 1989;
Nader and van der Kooy, 1997; Bechara et al., 1998). Lesions of
the rat PFC, specifically within the infralimbic (IFL) sub-region,
have been reported to block morphine CPP reward (Tzschentke
and Schmidt, 1999). Furthermore, opiate receptor transmission
in the VTA has been shown to modulate electrical brain self-
stimulation reward thresholds measured in the ventral pallidum
(Panagis et al., 1998).
Importantly, a substantial body of literature demonstrated
that blockade of the mesolimbic DA system, either via
neurochemical lesioning with 6-hydroxydopamine (6-OHDA)
or via administration of DA receptor antagonists, were able
to strongly attenuate the primary reinforcing properties of
opiates, measured in a variety of behavioral paradigms,
including intravenous self-administration (IVSA) and CPP
(Wise, 1989; Wise and Rompre, 1989). However, subsequent
reports demonstrated that the functional role of DA transmission
in the context of opiate-reward processing, depended crucially
upon the relative opiate exposure state of the animal. Thus, a
significant number of reports demonstrated that while the acute
rewarding effects of opiates could be mediated through non-
DAergic neural mechanisms, once animals became chronically
exposed to opiates such as morphine or heroin, the reinforcing
effects of opiates became dependent upon DA transmission
(Bechara and van der Kooy, 1989; Nader and van der Kooy, 1997;
Bechara et al., 1998). As will be discussed below, these studies
laid the foundation for characterizing both DA-dependent
and independent neural motivational pathways within the
mesolimbic system, and how opiate exposure states may control
the processing of opiate reward behaviors through distinct neural
circuits.
EXPOSURE STATE DETERMINES WHICH
NEURAL PATHWAYS CONTROL THE
PRIMARY REWARDING EFFECTS OF
OPIATES: EVIDENCE FOR AN OPIATE
ADDICTION “SWITCH?”
A critical consideration when investigating or theorizing about
the neural mechanisms controlling the motivational effects of
opiates, is the organism’s prior history of drug exposure. For
example, theoretical addiction frameworks focusing exclusively
on drug-related withdrawal phenomena, cannot account for
the acute effects of drug motivation nor the mechanisms
responsible for the initiation of drug use. Similarly, theoretical
frameworks focusing on drug-related sensitization or similar
plasticity mechanisms within neural reward pathways such as
the mesolimbic system, do not account for specific mechanisms
controlling the switch from the non-addicted to addicted neural
states or potential mechanisms underlying the reversibility
of addiction-related plasticity. The importance of identifying
discrete neural switching mechanisms controlling the transition
from non-dependent to drug-dependent motivational states
is particularly important in the context of opiate addiction.
Indeed, even a single exposure to high concentrations of
opiates such as morphine are capable of inducing acute
states of dependence and/or withdrawal (Larcher et al., 1998;
Kawasaki et al., 2011; Rothwell et al., 2012), highlighting the
potentially rapid and fluid nature of the opiate addiction
process.
A considerable body of basic neuroscience research has
indicated that the state of opiate exposure (e.g., previously naïve,
dependent, or dependent and in a state of withdrawal) can
regulate dissociable neural motivational circuits and mechanisms
controlling opiate reward processing. For example, Bechara et al.
(for review see Bechara et al., 1998) reported a functional
dissociation between two separate and dissociable neural
motivational pathways sub-serving the rewarding properties of
morphine, as a function of exposure and withdrawal state. Thus,
while excitotoxic lesions of the brainstem PPT only blocked
morphine reward CPP in previously opiate-naïve rats, these same
lesions were ineffective once rats were made opiate-dependent
and were conditioned in a state of drug withdrawal. In contrast,
systemic blockade of DA receptor transmission with a broad-
spectrum DA receptor antagonist failed to block opiate reward
effects in opiate-naïve rats, but completely blocked morphine
CPP when rats were conditioned while in a state of opiate-
dependence and withdrawal. This functional dissociation was
later localized directly to the VTA; thus, intra-VTA morphine
reward was shown to depend on the DA-independent, PPT
neural motivational system in the opiate naïve state, but switched
to a DA-dependent substrate once rats were conditioned in the
dependent and withdrawn states (Nader and van der Kooy,
1997). This apparent switch in brain reward signaling from the
naïve to dependent/withdrawn states was later replicated in rats
performing heroin IVSA (Olmstead et al., 1998), demonstrating
that regardless of Pavlovian or Operant conditioning paradigms,
the primary rewarding effects of opiates could be dissociated
between a drug-naïve, DA-independent system, and a DA-
dependent system once chronic exposure and withdrawal was
present (Nader and van der Kooy, 1997; Bechara et al., 1998;
Laviolette et al., 2002).
The molecular mechanisms underlying this switch were
later characterized as involving an alteration in the excitability
properties of VTA GABAA receptors, associated with non-
DAergic, presumptive GABAergic neurons (Laviolette and van
der Kooy, 2001; Laviolette et al., 2004). Thus, in opiate-naïve
rats, it was found that pharmacologically blocking inhibitory
VTA GABAA receptors activated a DA-independent behavioral
reward signaling pathway (mediated through the brainstem PPT;
Laviolette and van der Kooy, 2004). However, once rats were
made opiate-dependent and were in a state of withdrawal, VTA
GABAA receptors switched to an excitatory signaling state,
and now activated a DA-dependent reward signaling pathway
(mediated through the mesolimbic DA system). However, while
these intra-VTA opiate exposure plasticity mechanisms may
account for the primary rewarding effects of opiates, critical
questions remained. For example, how might opiate exposure
state control neuralmemory substrates controlling the associative
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memory effects of opiates? Do the neural substrates processing
these powerful, opiate-related associative memories similarly
depend upon a plasticity gradient, controlled by the brain’s state
of opiate dependence or withdrawal? Two neural regions sharing
substantial functional connectivity with the VTA and associated
DAergic transmission, are the BLA and PFC. Indeed, a large
body of evidence from both human and animal-based opiate
addiction models has pointed to a role for these neural regions
as important candidates mediating the processing of associative
memories linked to opiate reward and withdrawal behaviors.
ENCODING OF OPIATE REWARD MEMORY
IN THE AMYGDALA-PREFRONTAL
CORTICAL PATHWAY
The mammalian VTA and mesolimbic pathway share many
important functional connections with both cortical and sub-
cortical brain regions involved in emotional processing and
associative memory formation. Two regions in particular that
have been implicated in opiate-related learning and memory are
the PFC and BLA; both of which share functional connections
with each other, and receive important DAergic inputs from
the VTA. Evidence for the role of the PFC in both human
and animal-based models of opiate addiction come from a
variety of imaging, behavioral, and molecular studies. For
example, functional imaging studies have demonstrated that
the activation of PFC regions and associated cortical circuitry
is correlated with the expression and/or cue-induced recall
of associative memories linked to opiate-taking experiences in
human opiate-dependent subjects (Daglish et al., 2001; Luo
et al., 2004; Volkow et al., 2004; Langleben et al., 2008; Yang
et al., 2009). While human imaging studies are necessarily
limited in terms of anatomical and circuit-level resolution,
evidence from animal models of opiate addiction have revealed
important roles for neuronal networks within the PFC during
the encoding, recall, and extinction of opiate-related associative
memories.
For example, using chronically implanted micro-wire
recording arrays in the prelimbic cortex (PLC) of the rat,
Sun et al. (Figures 1A–C; Sun et al., 2011), reported that
sub-populations of PLC neurons were capable of encoding
opiate-related reward memories measured in a Pavlovian
conditioned place preference procedure (Figure 1D). Thus,
specific PLC neuronal subpopulations showed strong associative
neuronal activity, both in terms of firing frequency and bursting
levels, specifically during exposure to conditioned environmental
cues linked to the rewarding effects of morphine (Figure 1E).
Interestingly, PLC neuronal sub-populations demonstrated
specific patterns of firing activity depending upon the phase of
opiate reward memory processing (e.g., acquisition, recall or
extinction of the memories). Furthermore, detailed analysis of
these associative PLC neuronal activity patterns revealed several
differences between the firing modes of these cortical neurons;
for example, whether neurons were firing in regular, “tonic”
patterns vs. bursting in irregular spike trains. PLC neurons
were found to display divergent activity patterns of bursting
activity during the initial acquisition (e.g., memory encoding)
vs. the extinction (i.e., forgetting) of associative opiate reward
memories, with cortical neuron bursting activity selectively
increasing during the extinction phase of opiate-related memory
processing. Such findings were consistent with previous evidence
showing that neuronal populations in the rat PFC were capable
of showing differential response patterns during different phases
of opiate-related drug seeking behaviors (Chang et al., 1997).
Furthermore, evidence for a role of PFC neuronal ensemble
activation during reinstatement of extinguished heroin seeking
was demonstrated by Shalev et al. (2003), who reported that
reinstatement of heroin self-administration induced by acute
food deprivation could selectively induce c-fos activation in
PLC neuronal populations. In addition, Schmidt et al. (2005)
demonstrated that even after 3 weeks of heroin extinction
training and abstinence, cue-induced heroin self-administration
(but not reinstatement of sucrose seeking) in rats was correlated
with selective increases in zif268 (a molecular marker of early
gene activation) immunoreactivity in selective PLC neuronal
subpopulations. Together, such evidence suggests that, similar to
human imaging studies, prefrontal cortical regions are critical
for the storage and cue-related recall of associative opiate-reward
memories. However, considerable evidence has pointed to the
involvement of sub-cortical associative memory regions such as
the BLA as being important players in the processing of opiate-
related memories, particularly in terms of shared functional
connectivity with cortical regions.
Similar to effects described in the PFC, the BLA has been
reported to play a critical role in the processing of various forms
of opiate-related associative memories. Interestingly, despite
receiving substantial VTA DAergic inputs (Ford et al., 2006),
the BLA itself appears to play no role in the mediation of
opiate-related primary reinforcement effects (Olmstead and
Franklin, 1997). Rather, the functional role of the BLA as an
interface between VTA DAergic inputs and outputs to other
cortical and limbic regions (such as the PFC and NAc), position
this heterogeneous structure to sub-serve associative memory
functions. Indeed, single neurons within the BLA can encode
emotionally salient associative memories via the convergence
of DAergic inputs with sensory-associative information (Grace
and Rosenkranz, 2002; Rosenkranz and Grace, 2002). Not
surprisingly, the BLA has been implicated in the associative
properties of opiate-related learning and memory. For example,
pharmacological inactivation of the BLA has been shown to
abolish cue or heroin-induced reinstatement of extinguished
heroin-seeking behaviors in rats (Fuchs and See, 2002). Beyond
a role in processing reward-related properties of opiates, the
expression of opiate-withdrawal related aversion memories has
been linked to specific VTA-BLA neuronal activation patterns.
Using c-fos as a molecular marker of neuronal activation
patterns within the VTA>BLA network, Frenois et al. (2005)
reported that while BLA neuronal activation was involved
in the associative memory processing of opiate withdrawal,
neurons within the adjacent central nucleus (CeA) were
preferentially activated during acute withdrawal, independently
of conditioning, suggesting a more selective role for the BLA in
associative learning and memory components of opiate-related
Frontiers in Neuroscience | www.frontiersin.org 4 November 2015 | Volume 9 | Article 399
Rosen et al. Molecular basis of opiate addiction memories
A B C
D
E
FIGURE 1 | The encoding of associative opiate reward memories in PFC neuronal populations. (A,B) Microphotographs showing representative microwire
recording electrodes in the rat PFC. (C) A sample in vivo recording waveform showing a typical PFC neuronal trace. (D) Unbiased place conditioning (CPP) involves
randomly pairing the subject with a vehicle saline injection in one distinct environment, vs. a drug-injection (e.g., morphine) in an alternate conditioning environment.
Following multiple associative training sessions, animals are then asked to choose which environment to spend time in during the recall test, as a behavioral measure
of associative memory learning. If the animal recalls the rewarding effects of morphine, it will display a preference for the environment previously paired with the
rewarding properties of morphine. (E) A sample raster recording of a PFC neuron during a morphine CPP recall test. PFC neurons display robust associative increases
in firing, specifically in response to exposure to the previously experienced morphine-paired environments. Figure Adapted from Sun et al. (2011).
conditioned behaviors. Converging evidence from clinical studies
has further implicated the amygdala as an important component
of opiate-related cue processing. For example, Xie et al. (2011)
reported that impulsivity measures in heroin-abstinent subjects
were correlated with hyperactivity in an extended amygdala-
frontal cortical network. Thus, convergent evidence from
both animal and clinical based studies point to a significant
role for the BLA in both the storage and expression of
associative memories linked to both the acute and long-term
effects of opiate exposure. Furthermore, considerable evidence
points to important functional connectivity between the BLA
and PFC during the processing of opiate-related associative
information.
EVIDENCE FOR FUNCTIONAL BLA-PFC
INTERACTIONS IN ASSOCIATIVE
OPIATE-RELATED ADDICTION MEMORIES
The BLA and PFC share critical functional and anatomical
relationships and through bi-directional efferent and afferent
connections. In terms of the functional role of the BLA-PFC
pathway in human heroin addiction, little is known in terms
of molecular or neuronal mechanisms. However, in addition to
fMRI studies discussed previously, heroin dependent individuals
have been reported to display disturbances in both resting state
connectivity and functional activity relationships in the BLA-PFC
network (Zhang et al., 2011, 2015). Nevertheless, considerable
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evidence from animal models of opiate reward processing has
demonstrated important functional interconnections between
the BLA and PFC during both the acute acquisition and
the consolidation of associative opiate reward memories.
For example, Bishop et al. (2011) demonstrated that
pharmacologically inducing a state of NMDA receptor
hypofunction in the rat PFC was able to strongly potentiate the
reward salience of normally sub-reward threshold conditioning
doses of morphine, measured in a CPP procedure. Interestingly,
this effect was dependent upon active BLA inputs to the PFC,
since pharmacologically inactivating the BLA prior to PFC
modulation of NMDA transmission was sufficient to block PFC-
mediated modulation of opiate reward memory potentiation.
In terms of PFC neuronal involvement in the temporal
consolidation of opiate-related associative reward memories,
BLA inputs are critical. For example, Gholizadeh et al. (2013)
used targeted protein synthesis inhibition in the BLA → PFC
pathway to demonstrate that the acute, early consolidation
phase of an associativemorphine-rewardmemory was dependent
upon the BLA. However, during later phase consolidation,
PFC-dependent memory consolidation substrates were brought
online. Interestingly, this anatomically dissociable transfer
of opiate reward consolidation substrates along the BLA-
PFC pathway was dependent upon post-learning temporal
dynamics. Thus, BLA-dependent memory consolidation was
only required during the first 0–6 h post-conditioning and was
mediated through an extracellular-signal-regulated-kinase (ERK)
molecular substrate. In contrast, during later phases of memory
consolidation (6–12 h post-training), a PFC-dependent, calcium-
calmodulin-kinase-α, ERK-independent memory substrate was
activated. These findings demonstrated that during later phases
of addiction-related memory formation, PFC memory substrates
are specifically brought online, following a period of first-order
memory consolidation in sub-cortical limbic regions, such as
the BLA (Figure 2). Next, using microwire recordings of PFC
neurons combined with intra-BLA protein synthesis inhibition
at early vs. late phase consolidation of acute opiate associative
reward memory, Gholizadeh et al. (2013) demonstrated that
intra-BLA inhibition of associative opiate reward memory
consolidation, blocked associative PFC neuronal responses
during later CPP recall testing (Figure 3), further demonstrating
the ability of intra-BLA associative opiate reward memory
consolidation mechanisms to control remote consolidation in
PFC neuronal sub-populations.
Further demonstrating the importance of BLA inputs
to the PFC during associative opiate memory formation,
reversible inactivation of the BLA during opiate-related reward
learning was shown to increase the spontaneous firing and
bursting activity of rat PFC neurons and alter the longer-term
memory processing associated with opiate-related conditioning
effects. For example, Sun and Laviolette (2012) demonstrated
that pharmacologically inactivating the rat BLA during the
acquisition phase of opiate reward CPP conditioning causes a
later acceleration in the extinction of previously learned opiate
reward memories reflected in associative PFC neuronal activity
changes during conditioning. Thus, removing BLA input to the
PFC during associative opiate reward memory formation, led to
a less stable encoding of the memory which was more vulnerable
to extinction. Together, these findings demonstrate that specific
sub-populations of neurons in the mammalian PFC are capable
FIGURE 2 | The temporal dynamics of opiate reward memory consolidation within the BLA → PFC pathway. Targeted protein synthesis inhibition
with anisomycin within the BLA administered immediately after associative morphine CPP training (consolidation of memory phase) blocks associative opiate
reward memory consolidation only during the early phase of consolidation (0–6 h post-training). In contrast, targeting the PFC revealed that PFC-dependent
opiate reward memory consolidation occurred only during later-phase consolidation (6–12 h post-training). *p < 0.05; **p < 0.01. Figure Adapted from
Gholizadeh et al. (2013).
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FIGURE 3 | Blockade of intra-BLA associative opiate reward memory consolidation prevents the transfer of long-term opiate reward memories
to the PFC. (A) Blocking protein synthesis in the BLA at 0 h post-CPP training, prevents associative increases in PFC neuronal firing rates when tested 24 h
later. At 12 h, associative memory is already transferred to PFC neuronal populations and associative neuronal responses are present during the CPP recall
test phase. (B) A sample rastergram showing a typical PFC neurons associative response to morphine-environment exposure during the recall test, from a rat
receiving intra-BLA vehicle control infusions at 0 h post-training. (C) In contrast, blocking BLA protein synthesis at 0 h post-training with anisomycin,
completely blocks associative neuronal responding during the recall test phase, in this representative neuronal rastergram. **p < 0.01. Figure Adapted from
Gholizadeh et al. (2013).
of differentially encoding specific phases of addiction-related
memories and are governed by relatively precise temporal phases
of drug-reward exposure and active inputs from consolidation
mechanisms in the BLA. Furthermore, such evidence implicates
an important functional role for PFC neurons not only in the
initial acquisition of addiction-related associative memories, but
also in the later consolidation and recall of these memories.
OPIATE EXPOSURE STATE REGULATES
DOPAMINE RECEPTOR FUNCTION IN THE
BASOLATERAL AMYGDALA:
IMPLICATIONS FOR ASSOCIATIVE OPIATE
MEMORY FORMATION
In human heroin users, functional dysregulation between
amygdala and cortical cue reactivity networks has been correlated
with heightened sensitivity to drug-related cues (Liu et al.,
2009a). In terms of BLA involvement in the processing of
reward-related associative memory, DAergic inputs from the
VTA to the BLA have been demonstrated to modulate both
opiate-related motivational signaling and BLA neuronal activity
dynamics (Kröner et al., 2005; Ford et al., 2006). Nevertheless,
until recently, the underlying pharmacological and molecular
substrates underlying the functional role of the BLA in opiate-
related associative memory formation were not well understood.
The anatomical and functional position of the BLA as a
recipient of DAergic VTA inputs and location of functional
outputs regulating both NAc and PFC neuronal populations
(Floresco et al., 2001; Ford et al., 2006; Tan et al., 2011;
Lintas et al., 2012) suggests that neurons in the BLA may
function as an associative memory interface regulating opiate
memory formation. However, the precise roles of specific DA
receptor subtype transmission in the control of opiate memory
formation have only recently been elucidated. Using targeted
microinfusions of selective DA D1 vs. D2 receptor antagonists
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in rats, Lintas et al. (2011) demonstrated that transmission
through DA receptors directly in the BLA was able to potently
control the formation of associative morphine reward memories
as a function of opiate exposure state. Using an unbiased place
conditioning procedure to measure the rewarding properties of
morphine, the authors reported that while intra-BLA blockade
of the DA D1 receptor (D1R) with a selective D1R antagonist,
prevented the formation of opiate reward memories only in rats
that were conditioned in a previously opiate-naïve state, once rats
were chronically exposed to opiates and conditioned in a state
of withdrawal, the intra-BLA DA receptor substrate responsible
for the processing of associative morphine reward memories
switched to a DA D2 receptor (D2R)-dependent substrate. This
DA D1R/D2R receptor-dependent switch was dependent upon
downstream activation or inhibition of the cyclic AMP (cAMP)
signaling pathways as simultaneous intra-BLA co-administration
of a cAMP inhibitor reversed the behavioral effects of D1
receptor blockade on morphine CPP in the opiate-naïve state.
In contrast, in rats trained in a state of opiate-dependence
and in withdrawal, intra-BLA co-administration of a cAMP
activator, was shown to reverse the ability of intra-BLA D2
receptor blockade to prevent opiate reward memory formation.
In addition, the ability of BLA D1R/D2R receptor transmission
to control opiate reward memory formation was demonstrated
both for the processing of systemically applied morphine, and for
processing the direct, rewarding effects of intra-VTA morphine
infusions, demonstrating a functional link between VTA→ BLA
DAergic projections in the mediation of opiate related associative
memory acquisition (Lintas et al., 2011).
In follow-up studies, it was reported that intra-BLA
transmission through either DA D1 or D2 receptor substrates
could control not only the acquisition of associative opiate reward
memories, but also regulate the motivational salience of opiate-
related reward memories via functional interactions with the
NAc. Thus, infusions of either selective D1R or D2R agonists
directly into the BLA was shown to strongly increase the reward
salience of normally sub-reward threshold conditioning doses of
morphine, again, measured in a place conditioning procedure
(Lintas et al., 2012). Similar to the effects of intra-BLA D1R/D2R
blockade on opiate reward memory formation, the effects of
activating intra-BLA D1R/D2R substrates on morphine-reward
salience potentiation were dependent upon the opiate exposure
state of the animal; D1R activation only was effective in
previously opiate-naïve subjects, while D2R activation was only
effective when conditioning took place following chronic opiate
exposure and in the presence of withdrawal, again demonstrating
a functional transition between the D1R vs. D2R BLA receptor
systems as a function of opiate exposure state (Figure 4).
Given thewell-established importanceof theNAc inprocessing
of opiate-related rewardmemories and evidence that the BLA can
strongly regulate neuronal activity in the NAc via excitatory BLA
→ NAc inputs (Wise, 1989; Wise and Rompre, 1989; Floresco
et al., 2001). Lintas et al. (2012) next examined the potential role
of BLA→ NAc projections in mediating the effects of intra-BLA
D1R/D2R receptor transmission on opiate reward salience. They
reported that blocking NMDA receptor transmission selectively
in the shell region of the NAc (NASh) was sufficient to
block the opiate reward potentiating effects of intra-BLA DA
receptor activation. Interestingly, these behavioral effects were
correlated with the observation that intra-BLA D1R or D2R
activation could strongly potentiate NASh neuronal responses to
morphine administration, however, in line with the previously
observed behavioral dissociation, BLADAreceptor activationwas
demonstrated to follow the same functional boundary between
the opiate-naïve vs. chronic exposure and withdrawal states.
Thus, similar to the effects of D1R/D2R blockade, the BLA has
been demonstrated to control the motivational salience of opiate
reward memory formation via direct interactions with NASh
neuronal populations (Lintas et al., 2012).
The demonstration of a localized, intra-BLA D1R-D2R
memory switching mechanism as a function of opiate exposure
is consistent with previous reports demonstrating that chronic
opiate exposure and withdrawal may selectively induce
sensitization of D2R-dependent motivational pathways. An
early in vitro study using the isolated guinea pig ileum as a
model for opiate withdrawal, demonstrated that D2R agonists
and antagonists selectively controlled naloxone-induced tissue
contracture effects, while D1R agents showed little efficacy
(Capasso and Sorrentino, 1997). From a behavioral perspective,
Druhan et al. (2000), in a series of systemic behavioral
pharmacology experiments, demonstrated that rats displayed
heightened sensitivity to the locomotor activating effects of D2R
agonists specifically during spontaneous opiate withdrawal. In
contrast, D1R agonists had no effects. Similarly, Harris and
Aston-Jones (1994) demonstrated that direct activation of D2R
within the NAc, was capable of attenuating somatic and the
aversive behavioral effects of opiate withdrawal. Thus, while
these studies did not directly examined associative opiate reward
memory effects, they are nevertheless suggestive of a general
chronic opiate-induced mechanism, leading to a switch between
D1R to D2R-dependent physiological and behavioral substrates
controlling the transition from the naïve, to the dependent and
withdrawn opiate exposure states.
Nevertheless, important questions remain. For example, what
are the underlying molecular substrates linked to changes in the
functional properties of BLA D1/D2 receptors in the modulation
of opiate-related addiction memories? How might chronic
exposure to opiates induce this functional memory switch
within the VTA-BLA-NAc-PFC circuitry? As will be discussed
presently, considerable evidence now suggests that chronic opiate
exposure may control molecular memory adaptations within the
BLA-PFC circuitry via alterations in the phosphorylation states
of extracellular-signal-regulated kinases (ERK) and calcium-
calmodulin-kinase (CaMK) signaling families. Furthermore,
these adaptations may be functionally linked to intra-BLA
D1R/D2R regulation of opiate reward memory processing.
MOLECULAR MEMORY SUBSTRATES
CONTROLLING OPIATE MEMORY
FORMATION: ROLE OF ERK 1–2 AND
CAMKIIα-DEPENDENT MEMORY
PLASTICITY
The molecular underpinnings of associative, drug-related
memory formation, particularly at the neuronal and synaptic
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FIGURE 4 | Transmission through dopamine D1 vs. D2 receptor substrates in the rat BLA control the formation of associative opiate reward memories
as a function of opiate exposure state. Thus, in rats conditioned in a previously opiate-naïve state (A), blockade of intra-BLA D1 receptors dose-dependently
blocked the formation of associative opiate reward memories measured in a CPP procedure, through a cAMP-dependent molecular mechanism. In contrast, once
chronic opiate exposure and withdrawal has occurred (B), DA-dependent BLA opiate reward memory switches to a D2 receptor-dependent, cAMP mechanism,
independently of D1 transmission, as blockade of intra-BLA D2 transmission dose-dependently blocks opiate reward memory formation selectively in rats chronically
exposed to opiates and conditioned in a state of withdrawal. Figure Adapted from Lintas et al. (2011).
levels, are gradually beginning to be elucidated. Two neuronal
signaling pathways linked to DA receptor transmission and
which have been associated with drug-related reward processing
and memory formation are the extracellular-signal-regulated
kinases 1 and 2 (ERK1/2) and calcium/calmodulin-dependent
protein kinase II-α (CaMKIIα) systems. Evidence for the roles
of these pathways in drug-related learning and memory come
from various lines of evidence. For example, exposure to drug-
related conditioning cues using rodent models of drug self-
administration or associative conditioning has been repeatedly
shown to modulate ERK expression levels in a variety of
neural regions linked to reward-related processing, including the
amgydala, PFC and NAc (Lu et al., 2000, 2005; Mizoguchi et al.,
2004; Miller andMarshall, 2005; Valjent et al., 2006; Girault et al.,
2007; Lin et al., 2010; Li et al., 2011).
In the amygdala, dynamic ERK signaling events are associated
with various stages of drug-related memory processing. For
example, Wells et al. (2012) demonstrated that intra-BLA ERK
activation in the BLA was essential for processing of cocaine-
related associative memory reconsolidation. Li et al. (2008)
reported that ERK phosphorylation in the CeA was critical
for the incubation of opiate-related drug craving behaviors,
wherein the intensity of opiate-related associative drug-seeking
memory and behavior was demonstrated to increase throughout
an extended withdrawal period. Furthermore, the recall of
associative opiate-related reward memories has been linked
to ERK phosphorylation events in the rat BLA (Li et al.,
2011).
The CaMKIIα signaling pathway has similarly been associated
with various forms of drug-related memory processing. For
example, reinstatement of extinguished opiate-seeking behaviors
occurs in association with increased phosphorylation of
CaMKIIα at threonine 286 in the NAc shell but not core sub-
regions (Liu et al., 2012a). Furthermore, pharmacological
blockade of CaMKII signaling in the NAc shell blocks
reinstatement of morphine self-administration behaviors
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(Liu et al., 2012b). Chen et al. (2008) reported that long-term, but
not acute exposure to morphine led to upregulation in CaMKII
mRNA levels selectively in the hippocampus and PFC. In
contrast, long-term exposure to the synthetic heroin substitute,
methadone, was reported to downregulate phosphorylated levels
of CaMKIIα in the rat hippocampus, further suggesting that
chronic opiate exposure is capable of functionally modifying
levels of CaMKII (Andersen et al., 2012).
Importantly, in terms of DAergic transmission, signaling
through both D1R and D2R has been linked to downstream
modulation of ERK1/2 and CaMKIIα pathways. However,
considerable evidence suggests dissociable roles for D1R
vs. D2R subtypes their respective modulatory effects. Thus,
activation of D1R substrates within the mesocorticolimbic
pathway has been associated with phosphorylation of the ERK
1/2 signaling cascade. For example, administration of D1R
agonists has been reported to increase phosphorylation levels
of ERK selectively in the NAc and PFC, while D2 agonists
had no effect (Xue et al., 2015). In terms of reward-related
behavioral processing, Kirschmann et al. (2014) reported
that the ability of reward-related conditioned stimuli to
activate ERK signaling in the NAc, was mediated through a
D1R-NMDA dependent mechanism. Bertran-Gonzalez et al.
(2008) reported that psychostimulant-induced activation of
ERK phosphorylation in the NAc was confined exclusively
to D1R-containing striatal neurons, providing yet further
evidence for functional D1R-mediated selectivity over
downstream modulation of ERK phosphorylation events, at
least in the context of drug-related effects in the mesolimbic
system.
In contrast, regulation of D2R transmission has been linked
to downstream modulation of the CaMKII-signaling cascade
in various behavioral and molecular assays. First, at the cellular
level, D2R function is functionally linked to calcium signaling.
For example, the neuronal calcium sensor-1 (NCS-1) has
been shown to control desensitization of the D2R (Kabbani
et al., 2002; Woll et al., 2011), suggesting that ambient calcium
levels may importantly regulate D2R function. In terms of
drug-related modulation of D2R-CaMKII signaling, Liu et al.
(2009b) demonstrated that in NAc neurons, CaMKIIα is
recruited to the D3 receptor subtype (a member of the D2R
family which shows high expression levels in mesolimbic
areas), via elevations in calcium concentration. This in turn
increased the phosphorylation of the D3R, rendering it inactive
and insensitive to cocaine-induced behavioral activation.
Within the PFC, Lauzon et al. (2012) demonstrated that D4
receptor stimulation (another member of the D2R family)
potentiated the emotional salience of normally non-salient
fear-related associative memories via a CaMKII-dependent
signaling mechanism, further suggesting an important link
between associative memory formation and D2R-CaMKII-
dependent signaling integration. Thus, given evidence for
functionally dissociable roles for D1R/D2R transmission
via downstream modulation of ERK/CaMKII signaling
pathways, how might opiate exposure state regulate these
pathways in the context of associative opiate-related memory
formation?
OPIATE EXPOSURE STATE CONTROLS AN
ERK-CAMKII-DEPENDENT MOLECULAR
MEMORY SWITCH IN THE BASOLATERAL
AMYGDALA-PREFRONTAL CORTICAL
PATHWAY
To examine the potential molecular substrates controlling the
effects of chronic opiate exposure and withdrawal on BLA-
dependent associative opiate reward memory formation, Lyons
et al. (2013) performed a series of molecular and behavioral
studies in rats investigating the effects of opiate exposure state
on expression levels and functional roles of intra-BLA ERK 1/2
and CaMKII signaling pathways during associative opiate reward
memory formation. Given previous evidence demonstrating
a functional boundary between D1R vs. D2R transmission
controlling opiate reward memory formation as a function of
opiate exposure state (Lintas et al., 2011, 2012), the authors
tested if intra-BLA D1R-dependent associative morphine reward
memory may depend upon downstream phosphorylation of the
ERK 1/2 pathway in previously opiate-naïve rats. In addition, the
authors examined whether D2R-dependent memory formation
may involve phosphorylation of downstreamCaMKIIα signaling,
in the opiate-dependent and withdrawn state of exposure.
Consistent with these hypotheses, Lyons et al. (2013) reported
that pharmacological intra-BLA inhibition of ERK, selectively
blocked the acquisition of opiate reward memory formation in
the opiate naïve state. In contrast, inhibition of the CaMKII
signaling pathway blocked the formation of associative opiate
reward memory only in the chronically exposed and withdrawn
states. Similarly, the ability of intra-BLA D1R or D2R activation
to potentiate opiate reward salience was mediated through the
ERK signaling pathway in the naïve state, but switched to a
CaMKII dependent pathway once rats were chronically exposed
to opiates and in withdrawal (Lyons et al., 2013).
Concomitant with these behavioral dissociations, it was found
that phosphorylation levels of both ERK 1/2 and CaMKIIα were
dynamically regulated by opiate exposure levels. Thus, when
relative protein expression levels of ERK 1/2 and CaMKIIα
were measured in BLA tissue samples (Figure 5A) analysis
of phosphorylated levels of CaMKIIα revealed a striking and
dramatic reduction in total and phosphorylated levels of
CaMKIIα (but not in other CaMK isoforms, such as CaMKIIβ;
Figure 5B). In contrast, chronic opiate exposure and withdrawal
led to a significant reduction in relative BLA expression levels
of phosphorylated ERK 1 and 2 isoforms (Figures 5C,D). These
intra-BLA molecular alterations corresponded to behavioral
changes in sensitivity to intra-BLA blockade of CaMKII or
ERK signaling, respectively. Thus, blocking intra-BLA CaMKII
autophosphorylation blocked the acquisition of an opiate reward
memory selectively in rats that were conditioned in a state
of opiate dependence and withdrawal (Figure 5E). In contrast,
blocking intra-BLA ERK signaling was only able to block opiate
reward memory formation in rats conditioned in an opiate-naïve
state (Figure 5F). Finally, as described previously, intra-BLA
D1R or D2R activation with selective pharmacological activators
has been demonstrated to potentiate the reward salience of
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FIGURE 5 | Opiate exposure state controls the phosphorylation and functional roles of ERK 1/2 vs. CaMKIIα-dependent molecular memory substrates
in the BLA. (A) Using tissue punches from the BLA, Lyons et al. (2013) compared relative expression levels of CaMKIIα, ERK 1 and 2 total and phosphorylated levels
across opiate-naïve vs. chronically exposed/withdrawn states. (B) Relative to opiate-naïve rats, chronic opiate-exposure and withdrawal completely abolished protein
expression levels of both total and phosphorylated levels of CaMKIIα in the BLA. (C,D) In contrast, chronic opiate exposure and withdrawal selectively decreased
levels of intra-BLA phosphorylated ERK 1. (E) Using a CPP paradigm, the acquisition of associative opiate reward memories is dose-dependently blocked by
intra-BLA inhibition of CaMKII auto-phosphorylation with autocamtide-2-related inhibitory peptide (AIP), selectively in the chronic opiate exposure state. (F) In contrast,
intra-BLA inhibition of ERK signaling with U0126, selectively and dose-dependently blocked opiate reward memory formation in the opiate-naïve state. **p < 0.01.
Figure Adapted from Lyons et al. (2013).
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morphine conditioning cues measured in a CPP paradigm
(Lintas et al., 2012). In order to functionally link the effects
of intra-BLA D1R vs. D2R transmission with ERK vs. CaMKII
signaling mechanisms, Lyons et al. (2013) next demonstrated
that intra-BLA ERK inhibition was able to block the opiate
reward salience potentiation induced by D1R activation only
in the opiate-naïve state. In contrast, inhibition of CaMKII
selectively blocked the reward potentiating effects of intra-
BLA D2R activation, in the chronically exposed and withdrawn
exposure states.
Opiate exposure also results in alterations to the function
and expression of D2Rs and CaMKII in the PFC, although in
a manner opposite to that of the BLA. Rosen et al. (2015)
reported that chronic exposure to heroin lead to an upregulation
of the D2R and CaMKIIα, thus rendering opiate reward memory
formation resistant to inhibition of either the D2R or CaMKII,
which is otherwise sensitive to this blockade in the opiate naïve
state. Interestingly, this same study also found that simultaneous
contralateral inhibition of intra-BLA ERK1/2 and intra-PFC
CaMKII was sufficient to block the acquisition of an opiate
reward memory (Rosen et al., 2015). Unilateral inhibition of
either of these substrates was insufficient to block reward
memory formation, further pointing to the role of ERK and
CaMKII in opiate reward memory processing in both the BLA
and PFC.
In addition to their involvement in the processing of opiate-
related rewardmemories across different stages of drug exposure,
considerable evidence also implicates the ERK and CaMKII
signaling pathways in the processing of opiate-withdrawal related
associative memory formation. For example, using a naloxone-
induced opiate withdrawal conditioned place aversion (CPA)
procedure, wherein animals learn to avoid environments paired
with the aversive effects of opiate withdrawal, Wang et al.
(2015) reported that the extinction (unlearning) of naloxone CPA
memories was correlated with increased phosphorylation of both
the ERK and cAMP response element-binding protein (CREB)
in the dorsal hippocampus and BLA. Similarly, it was reported
that the extinction of associative opiate withdrawal memories
involved alterations in the epigenetic control of brain-derived
neurotrophic factor (BDNF) directly within the ventro-medial
region of the rat PFC. Interestingly, this mechanism depended
upon signaling via the ERK-CREB signaling cascade, through an
NMDA receptor-dependent mechanism (Wang et al., 2015).
Together, these findings demonstrate that ERK and CaMKII-
dependent memory substrates undergo profound adaptive
changes during specific phases of the opiate addiction process
and, within the BLA, are functionally linked to the modulatory
roles played by intra- D1R vs. D2R signaling mechanisms.
Furthermore, these studies underscore the importance of the
brain’s state of opiate exposure, serving as a functional boundary
between separate associative memory substrates controlling the
formation of opiate-related addiction memories.
SUMMARY AND FUTURE DIRECTIONS
Increasing evidence is revealing the importance of selective
molecular memory substrates within the BLA-PFC circuit as
important underlying mechanisms controlling opiate-addiction
related behavioral and neuronal plasticity. The overwhelming
importance of memory plasticity during the development and
maintenance of opiate addiction is demonstrated by these
profound molecular adaptations. Indeed, the picture that is
emerging from both clinical and animal-based studies suggests
that the mammalian brain undergoes a dramatic transformation
during the transition from a non-dependent to a dependent
state, characterized by discrete and selective molecular and
neuronal adaptations. Not only do critical neuroadaptations
take place in terms of mediating the primary rewarding
properties of opiates (Laviolette et al., 2004), but secondary,
associative memory “switching” mechanisms occur in neural
regions extrinsic to brain areas sub-serving opiate-related reward
processing. Nevertheless, many critical questions remain. Most
notably, how enduring are the observed molecular memory
adaptations within the BLA-PFC circuit? How might the
molecular adaptations observed within the BLA-PFC circuitry
relate to other aspects of opiate-related memory processing and
formation such as extinction and relapse phenomena? Of equal
importance, there is currently a dearth of clinical research in
human subjects examining the underlying molecular alterations
in amygdalar and cortical regions induced by chronic opiate
abuse. It is therefore of critical importance to verify that similar
molecular adaptations take place in the human brain, particularly
comparing the acute vs. chronic effects of opiate exposure on
cortical and sub-cortical memory circuits. Beyond the roles of
these molecular mechanisms in the process of opiate addiction,
considerable evidence has also implicated the ERK and CaMKII
signaling pathways as important modulators of other forms
of addiction, including psychostimulants such as cocaine and
amphetamine (Lu et al., 2005; Miller and Marshall, 2005; Valjent
et al., 2006; Girault et al., 2007; Wang et al., 2012; Wells et al.,
2012; Pizzo et al., 2014; Steinkellner et al., 2014). Thus, future
research will be necessary to identify both the similarities and
differences between how specific drug classes may specifically
regulate these pathways in the context of addiction-related
memory formation. Understanding these mechanisms will be
helpful in identifying potential commonmechanisms controlling
the switch from the non-dependent to drug-dependent states
across different drug classes and their associated receptor
targets.
In summary, identifying and characterizing the neuronal and
molecular events underlying the transition from the drug-naïve
to dependent states both anatomically and pharmacologically,
may offer the best hope for developing more effective
pharmacotherapies aimed at preventing or reversing the effects
of chronic opiate exposure and dependence. Indeed, the ability to
target the molecular adaptations responsible for the persistence
of drug-related associative memories may offer a novel and
powerful approach to attenuating the power of drug-related
associative memories over drug seeking and other compulsive
behavioral manifestations of opiate addiction.
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